American Oncology Network Appoints New Board Member
May 16 2024 - 4:30PM
American Oncology Network (AON) (Nasdaq: AONC), one of the nation’s
fastest-growing networks of community oncology practices, is
pleased to announce the appointment of William “Bill” J.
Valle to its Board of Directors, effective April 19, 2024.
“On behalf of the Board, I am honored to be officially welcoming
Bill,” said Stephen “Fred” Divers, MD, AON’s chief medical officer
and vice chairman of the Board. “Bill has extensive experience and
knowledge that will help guide AON on its mission forward. His
fresh perspectives and insights will serve as a catalyst for
innovation as we continue to close the cancer care gap and improve
access to cancer care and services. We are thrilled to have him
joining the Board.”
Valle’s vast experience includes serving in leadership positions
across a 14-year tenure at Fresenius Medical Care AG Management,
the leading provider of dialysis products, and Fresenius Medical
Care Holdings, Inc., a recognized solution for delivering
comprehensive chronic kidney disease care. Before that, he was the
president and chief executive officer of strategic advisory
services at Innovative Health Strategies, LLC.
Additionally, Valle has participated as a member of various
boards of Fresenius Medical Care AG Management, Fresenius Medical
Care Holdings, Inc., Sound Physicians, Interwell Health and Vifor
FMC Renal Pharma, Ltd.
“This is a tremendous opportunity to learn from a seasoned board
of healthcare leaders and contribute my knowledge and expertise to
AON, a company that I believe is making a true impact in the
communities it serves,” said Valle. “AON’s dedication to improving
cancer care access and creating equitable cancer care resonates
deeply with me. My background in driving healthcare solutions can
complement the Board’s existing strengths and help us collectively
achieve greater success and improve cancer care for years to
come.”
“We are confident that the addition of Bill will bring a wealth
of experience and knowledge to our Board,” said Todd Schonherz,
AON’s chief executive officer. “His passion for improved healthcare
is evident and fuels his willingness to participate on our Board.
Bill shares the vision of AON, and we are excited to be
collaborating with him to drive the company’s growth and success in
community oncology.”
Valle will join the other Board members, Dr. Divers, Todd
Schonherz, James Stith, Bradley M. Fluegel, and Ravi
Sarin.
For more information about AON, visit www.AONcology.com.
###
About American Oncology
Network
American Oncology Network (AON) (Nasdaq: AONC) is an alliance of
physicians and seasoned healthcare leaders partnering to ensure the
long-term success and viability of community oncology and other
specialties. Founded in 2018, AON's rapidly expanding network
represents more than 240 providers practicing across 21 states. AON
pioneers innovative healthcare solutions through its physician-led
model, fostering value-based care that improves patient outcomes
while reducing costs and expanding access to quality care. AON
equips its network physicians with the tools they need to thrive
independently while providing comprehensive support, integrated
revenue-diversifying ancillary services, and practice management
expertise, enabling physicians to focus on what matters most –
providing the highest standard of care for every patient. AON is
committed to promoting health equity by addressing disparities in
cancer care and ensuring that all patients have access to the care
they need to achieve optimal health outcomes. With a focus on
innovation and collaboration, AON is shaping the future of
community oncology. Learn more at www.AONcology.com.
- American Oncology Network Appoints New Board Member
Caroline Hewitt
American Oncology Network
941.224.8736
Caroline.Hewitt@AONcology.com
American Oncology Network (NASDAQ:AONC)
Historical Stock Chart
From Oct 2024 to Nov 2024
American Oncology Network (NASDAQ:AONC)
Historical Stock Chart
From Nov 2023 to Nov 2024